About Metrogel® 1%
Once-daily METROGEL (metronidazole) Gel, 1% is a topical gel that’s proven to effectively
treat the bumps and blemishes associated with rosacea. It has a unique patent-protected
formula that includes vitamin B3 to help retain your skin's natural moisture. It
is also the only branded prescription rosacea treatment that provides a measured dose for consistent delivery. Keep reading below to learn
more about METROGEL 1% features.
For an idea of METROGEL 1% effectiveness, just look at its prescription record: it's the #1 prescribed topical rosacea product for more than 10 years.
METROGEL 1% is also proven to work with just one application per day, and it has
a unique formula that enhances medication absorption while conditioning your skin.
Made with a unique formula
HSA-3® is what truly makes METROGEL 1% different. But what is it? It’s a formula
that combines three ingredients that together improve how the METROGEL 1% solution
works on your skin, enhancing absorption of the active ingredient, metronidazole,
while also helping to retain your skin's natural moisture.
Available in a measured-dose pump
The METROGEL 1% Pump is the only branded prescription rosacea treatment delivery system of its kind. Learn more about the treatment delivery system - take an interactive tour of the pump now.
*Restrictions may apply. See program details for more information.
IMPORTANT SAFETY INFORMATION
Indication: METROGEL® 1% is indicated
for the topical treatment of the inflammatory lesions of rosacea. Adverse Events:
In controlled clinical studies, the most commonly reported adverse events (>2%)
in patients treated with METROGEL 1% were nasopharyngitis, upper respiratory tract
infection, and headache. Other adverse experiences reported when using topical metronidazole
include skin irritation, transient redness, metallic taste, tingling or numbness
of the extremities and nausea. Warnings/Precautions: METROGEL 1%
should not be used by patients who are allergic to metronidazole or any ingredient
in METROGEL 1%. Avoid contact of METROGEL 1% with the eyes as it may cause tearing.
METROGEL 1% should be used with caution in patients with evidence of, or a history
of, blood dyscrasia, and with patients taking blood thinning agents as they may
experience prolonged prothrombin times. METROGEL 1% treatment should be discontinued
if numbness or paresthesia of any extremity should occur.
You are encouraged to report negative side effects of prescription drugs to the
FDA. Visit www.fda.gov/medwatch
or call 1-800-FDA-1088.